Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentazocine/Naloxone for Menopausal Hot Flashes
NCT02070718Phase 1Completed
- Sponsor
- University of Washington
- Start
- Jan 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pentazocine in vasomotor symptoms (3 arms), sponsored by University of Washington. Primary endpoint: Hot Flashes Frequency. Started Jan 2013; status: completed.
02
Drugs
pentazocine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT02070718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070718.